Get the Stockscreener App
7.0101
13.46%
-1.0899
After Hours:
7.30
0.2899
+4.14%
Addex Therapeutics Ltd Adr stock is traded at $7.0101, with a volume of 1,352.
It is down -13.46% in the last 24 hours and down -17.24% over the past month.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
See More
Previous Close:
$8.10
Open:
$7.0101
24h Volume:
1,352
Relative Volume:
0.06
Market Cap:
$8.64M
Revenue:
$630.00K
Net Income/Loss:
$5.72M
P/E Ratio:
-20.53
EPS:
-0.3415
Net Cash Flow:
$-6.75M
1W Performance:
-12.92%
1M Performance:
-17.24%
6M Performance:
-16.38%
1Y Performance:
-12.37%
1-Day Range:
$7.0101
$7.0101
1-Week Range:
$7.0101
$8.10
52-Week Range:
$6.51
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Name
Addex Therapeutics Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare ADXN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
7.0101 | 9.98M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Stock (ADXN) Latest News
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges - TipRanks
Addex Therapeutics Reports Q3 2025 Financial Results - TipRanks
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings By Investing.com - Investing.com South Africa
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings - Investing.com India
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Total debt per share of Addex Therapeutics Ltd Sponsored ADR – MUN:APE1 - TradingView
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 5.5% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
How geopolitical risks impact Addex Therapeutics Ltd (APE) stockShare Buyback & Consistent Growth Equity Picks - newser.com
[F-3] Addex Therapeutics Ltd. Foreign Issuer Shelf Registration | ADXN SEC FilingForm F-3 - Stock Titan
Why Addex Therapeutics Ltd (APE) stock stays on buy listsJuly 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Short Interest in Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Grows By 61.0% - Defense World
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Short Interest Down 91.1% in September - Defense World
Revenue per share of Addex Therapeutics Ltd Sponsored ADR – BER:APE1 - TradingView
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges - MSN
Addex Therapeutics (NASDAQ:ADXN) Shares Up 5.6% – Here’s What Happened - Defense World
Addex Therapeutics’ (ADXN) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Sees Significant Increase in Short Interest - Defense World
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - TipRanks
Addex Therapeutics H1 2025 Earnings Call Transcript - MarketBeat
Will V.F. Corporation (VFP) stock see valuation expansionExit Point & AI Driven Stock Movement Reports - newser.com
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Lion Group (NASDAQ:LGHL) Stock Price Down 4.3% – Here’s Why - Defense World
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - MSN
Can trapped investors hope for a rebound in Vine Hill Capital Investment Corp.Quarterly Profit Report & Pattern Based Trade Signal System - newser.com
Applying sector rotation models to Quipt Home Medical Corp.Portfolio Profit Report & Expert Verified Stock Movement Alerts - newser.com
Is This The Best Time To Buy iSpecimen Inc (NASDAQ: ISPC) Stock? - stocksregister.com
How to read the order book for Addex Therapeutics Ltd Depositary ReceiptInsider Buying & Long Hold Capital Preservation Plans - Newser
What earnings revisions data tells us about Core Scientific Inc.Earnings Summary Report & Daily Stock Momentum Reports - Newser
Strategies to average down on Addex Therapeutics Ltd Depositary ReceiptPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Should you hold or exit SONY nowExit Point & Intraday High Probability Setup Alerts - Newser
Can trapped investors hope for a rebound in Titan Machinery Inc.Earnings Recap Summary & AI Enhanced Execution Alerts - Newser
Real time pattern detection on Grayscale Bitcoin Mini Trust stock3-Day Market Movement Forecast Analysis - Newser
Can GSK plc ADRhedged hit a new high this monthSmart Entry Signals for Active Traders - Newser
Combining price and volume data for Flux Power Holdings Inc.Free AI Driven Stock Trend Forecast - Newser
Most active stocks: US stocks with the highest trading volume today - Yahoo.co
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 4.5% – Here’s Why - Defense World
ADR Ratio Change - Yahoo
Addex Therapeutics Reports Q1 2025 Financial Results - TipRanks
Addex Therapeutics Ltd Stock Price Today | NASDAQ: ADXN Live - Investing.com
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewswire Inc.
European Equities See Growth In US ADR Market - Finimize
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Addex Stock Soars on Crucial Update From Indivior Research Deal - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Is Alcon (ALC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2025 - MarketBeat
Earnings call: Addex Therapeutics reports on collaborations and financials - Investing.com
Addex Therapeutics Ltd Adr Stock (ADXN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):